The potential role of nintedanib in treating colorectal cancer. [electronic resource]
Producer: 20171103Description: 1153-1162 p. digitalISSN:- 1744-7666
- Angiogenesis Inhibitors -- administration & dosage
- Colorectal Neoplasms -- blood supply
- Humans
- Indoles -- administration & dosage
- Neovascularization, Pathologic -- drug therapy
- Randomized Controlled Trials as Topic
- Receptors, Fibroblast Growth Factor -- antagonists & inhibitors
- Receptors, Platelet-Derived Growth Factor -- antagonists & inhibitors
- Treatment Outcome
- Vascular Endothelial Growth Factor Receptor-1 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.